CHICAGO -- Upfront surgery for advanced ovarian cancer failed to improve overall survival (OS) versus interval debulking but did improve progression-free survival (PFS) for the first time in a ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival compared with neoadjuvant chemo and interval cytoreductive surgery.

Facility-level disparities in adopting minimally invasive interval debulking surgery for ovarian cancer highlight urgent needs for equitable care access.

After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.

Michael J. Worley, Jr., MD, Director of Ovarian Cancer Surgery at Brigham and Women’s Hospital in Boston, provides an update on identifying the subset of patients who are most likely to benefit ...

Results from TUBA and WISP show high-risk women have few remaining cancer worries or decision regrets after undergoing prophylactic surgery to reduce ovarian cancer risk.

To prevent ovarian cancers, fallopian tube removal is on an upsurge — and diagnostic manuals are finally catching up.